Details of the Researcher

PHOTO

Shun Shibata
Section
Graduate School of Medicine
Job title
Assistant Professor
Degree
  • 博士(医学)(大阪大学)

  • 修士(生命科学)(東北大学)

e-Rad No.
40885670

Research History 3

  • 2020/04 - Present
    Tohoku University Graduate School of Medicine Assistant Professor

  • 2014/06 - 2020/03
    Osaka University Graduate School of Medicine Research Scientist

  • 2012/04 - 2014/05
    ROHTO Pharmaceutical Co., Ltd. R&D division Scientist

Education 2

  • Tohoku University

    2010/04 - 2012/03

  • Osaka Metropolitan University

    2006/04 - 2010/03

Research Areas 1

  • Life sciences / Developmental biology /

Awards 5

  1. 第7回日本医療研究開発大賞 AMED理事長賞

    2025/01 内閣府 健康・医療戦略推進事務局

  2. 第28回日本生殖内分泌学会学術集会 学術奨励賞

    2023/11 日本生殖内分泌学会

  3. 第52回日本結合組織学会学術大会 Yong Investigator Award

    2020/09 日本結合組織学会

  4. 第24回眼科分子生物学研究会 若手研究奨励賞

    2020/01 眼科分子生物学研究会

  5. ロートクロスイノベーションアワード

    2017/12 ロートクロスイノベーションフォーラム2017

Papers 22

  1. Syncytin-1 Is Responsible for the Fusion Between Human Trophoblasts and Endometrial Stromal Cells.

    Akira Oike, Shun Shibata, Takahiro Arima, Hiroaki Okae

    Development, growth & differentiation 2025/06/12

    DOI: 10.1111/dgd.70014  

    More details Close

    Syncytiotrophoblasts (STs) are multinucleated cells formed by the fusion of trophoblasts and play critical roles in placental development and function. Retrovirus-derived fusogenic proteins, known as syncytins, regulate trophoblast fusion by interacting with specific receptors. In humans, two syncytins, Syncytin-1 (Syn1) and Syncytin-2 (Syn2), have been identified. Although both are considered to be involved in ST formation, the expression patterns of Syn1, Syn2, and their receptors differ significantly, suggesting that Syn1 and Syn2 may have distinct roles. To investigate the functional differences of syncytins in human trophoblasts, we generated Syn1 and Syn2 knockout (KO) human trophoblast stem cells (hTSCs). ST differentiation assays revealed that Syn2 plays a predominant role in trophoblast-trophoblast fusion. We also examined the fusion between hTSCs and endometrial stromal cells (EMSCs), as trophoblasts and EMSCs interact directly during implantation, and genes encoding Syn1 and Syn2 receptors are expressed in EMSCs. This analysis revealed that hTSCs do fuse with EMSCs, and in contrast to trophoblast-trophoblast fusion, Syn1 plays a predominant role in trophoblast-EMSC fusion. Given that fusion-capable Syn1 is found only in primates whose embryos invade deep into the uterus, we hypothesize that Syn1 may be more involved in implantation rather than in trophoblast-trophoblast fusion.

  2. Recapitulating human embryo implantation using stem cells and organoids Peer-reviewed

    Shun Shibata, Takahiro Arima

    Translational and Regulatory Sciences 6 (3) 68-71 2024/12/20

    Publisher: AMED iD3 Catalyst Unit

    DOI: 10.33611/trs.2024-004  

    eISSN: 2434-4974

  3. Common and uncommon findings in marmoset and human trophoblast stem cells. International-journal Peer-reviewed

    Hiroaki Okae, Shun Shibata, Takahiro Arima

    Cell Stem Cell 31 (10) 1387-1388 2024/10/03

    DOI: 10.1016/j.stem.2024.07.008  

    More details Close

    In this issue of Cell Stem Cell, Siriwardena et al. analyze peri- and post-implantation marmoset trophoblast development in detail and establish marmoset trophoblast stem cell (TSC) lines from pluripotent stem cells (PSCs). Comparative analysis of marmoset and human TSCs provides insights into species-specific implantation and placentation strategies.

  4. Modeling embryo-endometrial interface recapitulating human embryo implantation Peer-reviewed

    Shun Shibata, Shun Endo, Luis A. E. Nagai, Eri H. Kobayashi, Akira Oike, Norio Kobayashi, Akane Kitamura, Takeshi Hori, Yuji Nashimoto, Ryuichiro Nakato, Hirotaka Hamada, Hirokazu Kaji, Chie Kikutake, Mikita Suyama, Masatoshi Saito, Nobuo Yaegashi, Hiroaki Okae, Takahiro Arima

    Science Advances 10 (8) 2024/02/23

    Publisher: American Association for the Advancement of Science (AAAS)

    DOI: 10.1126/sciadv.adi4819  

    ISSN: 1881-3704

    eISSN: 2375-2548

    More details Close

    The initiation of human pregnancy is marked by the implantation of an embryo into the uterine environment; however, the underlying mechanisms remain largely elusive. To address this knowledge gap, we developed hormone-responsive endometrial organoids (EMO), termed apical-out (AO)–EMO, which emulate the in vivo architecture of endometrial tissue. The AO-EMO comprise an exposed apical epithelium surface, dense stromal cells, and a self-formed endothelial network. When cocultured with human embryonic stem cell–derived blastoids, the three-dimensional feto-maternal assembloid system recapitulates critical implantation stages, including apposition, adhesion, and invasion. Endometrial epithelial cells were subsequently disrupted by syncytial cells, which invade and fuse with endometrial stromal cells. We validated this fusion of syncytiotrophoblasts and stromal cells using human blastocysts. Our model provides a foundation for investigating embryo implantation and feto-maternal interactions, offering valuable insights for advancing reproductive medicine.

  5. Trophoblast stem cell-based organoid models of the human placental barrier. International-journal Peer-reviewed

    Takeshi Hori, Hiroaki Okae, Shun Shibata, Norio Kobayashi, Eri H Kobayashi, Akira Oike, Asato Sekiya, Takahiro Arima, Hirokazu Kaji

    Nature Communications 15 (1) 962-962 2024/02/08

    DOI: 10.1038/s41467-024-45279-y  

    More details Close

    Human placental villi have essential roles in producing hormones, mediating nutrient and waste exchange, and protecting the fetus from exposure to xenobiotics. Human trophoblast organoids that recapitulate the structure of villi could provide an important in vitro tool to understand placental development and the transplacental passage of xenobiotics. However, such organoids do not currently exist. Here we describe the generation of trophoblast organoids using human trophoblast stem (TS) cells. Following treatment with three kinds of culture medium, TS cells form spherical organoids with a single outer layer of syncytiotrophoblast (ST) cells that display a barrier function. Furthermore, we develop a column-type ST barrier model based on the culture condition of the trophoblast organoids. The bottom membrane of the column is almost entirely covered with syndecan 1-positive ST cells. The barrier integrity and maturation levels of the model are confirmed by measuring transepithelial/transendothelial electrical resistance (TEER) and the amount of human chorionic gonadotropin. Further analysis reveals that the model can be used to derive the apparent permeability coefficients of model compounds. In addition to providing a suite of tools for the study of placental development, our trophoblast models allow the evaluation of compound transfer and toxicity, which will facilitate drug development.

  6. CRISPR screening in human trophoblast stem cells reveals both shared and distinct aspects of human and mouse placental development. International-journal Peer-reviewed

    Takanori Shimizu, Akira Oike, Eri H Kobayashi, Asato Sekiya, Norio Kobayashi, Shun Shibata, Hirotaka Hamada, Masatoshi Saito, Nobuo Yaegashi, Mikita Suyama, Takahiro Arima, Hiroaki Okae

    Proceedings of the National Academy of Sciences of the United States of America 120 (51) e2311372120 2023/12/19

    DOI: 10.1073/pnas.2311372120  

    More details Close

    The placenta serves as the interface between the mother and fetus, facilitating the exchange of gases and nutrients between their separate blood circulation systems. Trophoblasts in the placenta play a central role in this process. Our current understanding of mammalian trophoblast development relies largely on mouse models. However, given the diversification of mammalian placentas, findings from the mouse placenta cannot be readily extrapolated to other mammalian species, including humans. To fill this knowledge gap, we performed CRISPR knockout screening in human trophoblast stem cells (hTSCs). We targeted genes essential for mouse placental development and identified more than 100 genes as critical regulators in both human hTSCs and mouse placentas. Among them, we further characterized in detail two transcription factors, DLX3 and GCM1, and revealed their essential roles in hTSC differentiation. Moreover, a gene function-based comparison between human and mouse trophoblast subtypes suggests that their relationship may differ significantly from previous assumptions based on tissue localization or cellular function. Notably, our data reveal that hTSCs may not be analogous to mouse TSCs or the extraembryonic ectoderm (ExE) in which in vivo TSCs reside. Instead, hTSCs may be analogous to progenitor cells in the mouse ectoplacental cone and chorion. This finding is consistent with the absence of ExE-like structures during human placental development. Our data not only deepen our understanding of human trophoblast development but also facilitate cross-species comparison of mammalian placentas.

  7. Ocular instillation of conditioned medium from mesenchymal stem cells is effective for dry eye syndrome by improving corneal barrier function Peer-reviewed

    Tsutomu Imaizumi, Ryuhei Hayashi, Yuji Kudo, Xiaoqin Li, Kaito Yamaguchi, Shun Shibata, Toru Okubo, Tsuyoshi Ishi, Yoichi Honma, Kohji Nishida

    Scientific Reports 2023/04/03

    Publisher: Research Square Platform LLC

    DOI: 10.21203/rs.3.rs-2711893/v1  

    More details Close

    Abstract Dry eye syndrome (DES) is a chronic ocular disease that induces epithelial damage to the cornea by decreasing tear production and quality. Adequate treatment options have not been established for severe DES such as Sjogren’s syndrome due to complicated pathological conditions. To solve this problem, we focused on the conditioned medium of human adipose-derived mesenchymal stem cells (hAdMSC-CM), which have multiple therapeutic properties. Here, we showed that hAdMSC-CM suppressed Benzalkonium Chloride (BAC)-induced cytotoxicity and inflammation in human corneal epithelial cells (hCECs). In addition, hAdMSC-CM increased the expression level and regulated the localisation of barrier function-related components, and improved the BAC-induced barrier dysfunction in hCECs. RNA-seq analysis and inhibition experiments revealed that the effects of hAdMSC-CM were associated with the TGFβ and JAK-STAT signalling pathways. Moreover, inDES model rats with exorbital and intraorbital lacrimal gland excision, ocular instillation of hAdMSC-CM suppressed corneal epithelial damage by improving barrier dysfunction of the cornea. Thus, we demonstrated that hAdMSC-CM has multiple therapeutic properties associated with TGFβ and JAK-STAT signalling pathways, and ocular instillation of hAdMSC-CM may serve as an innovative therapeutic agent for DES by improving corneal barrier function.

  8. Genomic imprinting in human placentation. Peer-reviewed

    Eri H Kobayashi, Shun Shibata, Akira Oike, Norio Kobayashi, Hirotaka Hamada, Hiroaki Okae, Takahiro Arima

    Reproductive Medicine and Biology 21 (1) e12490 2022/12

    DOI: 10.1002/rmb2.12490  

    More details Close

    BACKGROUND: Genomic imprinting (GI) is a mammalian-specific epigenetic phenomenon that has been implicated in the evolution of the placenta in mammals. METHODS: Embryo transfer procedures and trophoblast stem (TS) cells were used to re-examine mouse placenta-specific GI genes. For the analysis of human GI genes, cytotrophoblast cells isolated from human placental tissues were used. Using human TS cells, the biological roles of human GI genes were examined. MAIN FINDINGS: (1) Many previously identified mouse GI genes were likely to be falsely identified due to contaminating maternal cells. (2) Human placenta-specific GI genes were comprehensively determined, highlighting incomplete erasure of germline DNA methylation in the human placenta. (3) Human TS cells retained normal GI patterns. (4) Complete hydatidiform mole-derived TS cells were characterized by aberrant GI and enhanced trophoblastic proliferation. The maternally expressed imprinted gene p57KIP2 may be responsible for the enhanced proliferation. (5) The primate-specific microRNA cluster on chromosome 19, which is a placenta-specific GI gene, is essential for self-renewal and differentiation of human TS cells. CONCLUSION: Genomic imprinting plays diverse and important roles in human placentation. Experimental analyses using TS cells suggest that the GI maintenance is necessary for normal placental development in humans.

  9. The microRNA cluster C19MC confers differentiation potential into trophoblast lineages upon human pluripotent stem cells Peer-reviewed

    Norio Kobayashi, Hiroaki Okae, Hitoshi Hiura, Naoto Kubota, Eri H. Kobayashi, Shun Shibata, Akira Oike, Takeshi Hori, Chie Kikutake, Hirotaka Hamada, Hirokazu Kaji, Mikita Suyama, Marie-Line Bortolin-Cavaillé, Jérôme Cavaillé, Takahiro Arima

    Nature Communications 13 (1) 2022/06/02

    Publisher: Springer Science and Business Media LLC

    DOI: 10.1038/s41467-022-30775-w  

    eISSN: 2041-1723

    More details Close

    Abstract The first cell fate commitment during mammalian development is the specification of the inner cell mass and trophectoderm. This irreversible cell fate commitment should be epigenetically regulated, but the precise mechanism is largely unknown in humans. Here, we show that naïve human embryonic stem (hES) cells can transdifferentiate into trophoblast stem (hTS) cells, but primed hES cells cannot. Our transcriptome and methylome analyses reveal that a primate-specific miRNA cluster on chromosome 19 (C19MC) is active in naïve hES cells but epigenetically silenced in primed ones. Moreover, genome and epigenome editing using CRISPR/Cas systems demonstrate that C19MC is essential for hTS cell maintenance and C19MC-reactivated primed hES cells can give rise to hTS cells. Thus, we reveal that C19MC activation confers differentiation potential into trophoblast lineages on hES cells. Our findings are fundamental to understanding the epigenetic regulation of human early development and pluripotency.

  10. Generation of 3D lacrimal gland organoids from human pluripotent stem cells. International-journal Peer-reviewed

    Ryuhei Hayashi, Toru Okubo, Yuji Kudo, Yuki Ishikawa, Tsutomu Imaizumi, Kenji Suzuki, Shun Shibata, Tomohiko Katayama, Sung-Joon Park, Robert D Young, Andrew J Quantock, Kohji Nishida

    Nature 2022/04/20

    DOI: 10.1038/s41586-022-04613-4  

    More details Close

    Lacrimal glands are the main exocrine glands of the eyes. Situated within the orbit, behind the upper eyelid and towards the temporal side of each eye, they secrete lacrimal fluid as a major component of the tear film. Here we identify cells with characteristics of lacrimal gland primordia that emerge in two-dimensional eye-like organoids cultured from human pluripotent stem cells1. When isolated by cell sorting and grown under defined conditions, the cells form a three-dimensional lacrimal-gland-like tissue organoid with ducts and acini, enabled by budding and branching. Clonal colony analyses indicate that the organoids originate from multipotent ocular surface epithelial stem cells. The organoids exhibit notable similarities to native lacrimal glands on the basis of their morphology, immunolabelling characteristics and gene expression patterns, and undergo functional maturation when transplanted adjacent to the eyes of recipient rats, developing lumina and producing tear-film proteins.

  11. Effects of the dipeptide L-glutamic acid-L-tryptophan on dermatitis in mice and human keratinocytes. International-journal Peer-reviewed

    Shun Shibata, Akiko Kuwahara, Masayo Sakaki-Yumoto, Makoto Kawaguchi, Tsuyoshi Ishii, Yoichi Honma

    Heliyon 8 (1) e08729 2022/01

    DOI: 10.1016/j.heliyon.2022.e08729  

    More details Close

    Allergic contact dermatitis (ACD) and atopic dermatitis (AD) are inflammatory eczematous skin diseases caused by various factors. Here, we report that topical application of the dipeptide, L-glutamic acid-L-tryptophan (L-Glu-L-Trp), improved symptoms in both ACD and AD in mice. Using a mouse model of ACD induced by repeated application of 2,4-dinitorofluorbenzene (DNFB), we demonstrated that L-Glu-L-Trp attenuated DNFB-induced skin thickening. In addition, quantification of cytokines in serum revealed that L-Glu-L-Trp suppressed the DNFB-induced increase in the interleukin (IL)-22 level. Moreover, L-Glu-L-Trp attenuated mite antigen extract-induced AD model symptoms such as the increase of skin thickening and elevation of serum IL-22. We also confirmed that the dipeptide structure rather than the individual amino acid components was important for the therapeutic effects of L-Glu-L-Trp. Furthermore, we showed that IL-22 decreased the expression level of filaggrin mRNA in human epidermal keratinocytes, and L-Glu-L-Trp attenuated that effect. These results suggested that the topical application of the dipeptide, L-Glu-L-Trp, to the skin may be useful for treating ACD and AD.

  12. L-(+)-Tartaric Acid Minimally Affects the Viability or Molecular Signature but Increase the Expression of Selected Hair Growth Associated Genes in Human Dermal Papilla Cells Peer-reviewed

    Sayo Kashiwagi, Manabu Ohyama, Hsin-Ru Chan, Shun Shibata, Mihoko Yoshino, Eri Mori, Takashi Shimizu, Tsuyoshi Ishii

    Journal of Cosmetology & Trichology 7:2 (2021) 147-151 2021/02/12

  13. Unique features and emerging in vitro models of human placental development. Peer-reviewed

    Shun Shibata, Eri H Kobayashi, Norio Kobayashi, Akira Oike, Hiroaki Okae, Takahiro Arima

    Reproductive Medicine and Biology 19 (4) 301-313 2020/10

    DOI: 10.1002/rmb2.12347  

    More details Close

    Background: The placenta is an essential organ for the normal development of mammalian fetuses. Most of our knowledge on the molecular mechanisms of placental development has come from the analyses of mice, especially histopathological examination of knockout mice. Choriocarcinoma and immortalized cell lines have also been used for basic research on the human placenta. However, these cells are quite different from normal trophoblast cells. Methods: In this review, we first provide an overview of mouse and human placental development with particular focus on the differences in the anatomy, transcription factor networks, and epigenetic characteristics between these species. Next, we discuss pregnancy complications associated with abnormal placentation. Finally, we introduce emerging in vitro models to study the human placenta, including human trophoblast stem (TS) cells, trophoblast and endometrium organoids, and artificial embryos. Main findings: The placental structure and development differ greatly between humans and mice. The recent establishment of human TS cells and trophoblast and endometrial organoids enhances our understanding of the mechanisms underlying human placental development. Conclusion: These in vitro models will greatly advance our understanding of human placental development and potentially contribute to the elucidation of the causes of infertility and other pregnancy complications.

  14. Ocular surface ectoderm instigated by WNT inhibition and BMP4. International-journal Peer-reviewed

    Yuki Kobayashi, Ryuhei Hayashi, Shun Shibata, Andrew J Quantock, Kohji Nishida

    Stem Cell Research 46 101868-101868 2020/07

    DOI: 10.1016/j.scr.2020.101868  

    More details Close

    We sought to elucidate how and when the ocular surface ectoderm commits to its differentiation into the corneal epithelium in eye development from human induced pluripotent stem cells (hiPSCs) under the influence of WNT signaling and the actions of BMP4. These signals are key drivers ocular surface ectodermal cell fate determination. It was discovered that secreted frizzled related protein-2 (SFRP2) and Dickkopf1 (DKK1), which are expressed in neural ectoderm, are both influential in the differentiation of hiPSCs, where they act as canonical WNT antagonists. BMP4, moreover, was found to simultaneously initiate non-neural ectodermal differentiation into a corneal epithelial lineage. Combined treatment of hiPSCs with exogenous BMP4 aligned to WNT inhibition for the initial four days of differentiation increased the ocular surface ectodermal cell population and induced a corneal epithelial phenotype. Specification of a surface ectodermal lineage and its fate is thus determined by a fine balance of BMP4 exposure and WNT inhibition in the very earliest stages of human eye development.

  15. Cell-Type-Specific Adhesiveness and Proliferation Propensity on Laminin Isoforms Enable Purification of iPSC-Derived Corneal Epithelium. International-journal Peer-reviewed

    Shun Shibata, Ryuhei Hayashi, Yuji Kudo, Toru Okubo, Tsutomu Imaizumi, Tomohiko Katayama, Yuki Ishikawa, Yuki Kobayashi, Junko Toga, Yukimasa Taniguchi, Yoichi Honma, Kiyotoshi Sekiguchi, Kohji Nishida

    Stem Cell Reports 14 (4) 663-676 2020/04/14

    DOI: 10.1016/j.stemcr.2020.02.008  

    More details Close

    A treatment for intractable diseases is expected to be the replacement of damaged tissues with products from human induced pluripotent stem cells (hiPSCs). Target cell purification is a critical step for realizing hiPSC-based therapy. Here, we found that hiPSC-derived ocular cell types exhibited unique adhesion specificities and growth characteristics on distinct E8 fragments of laminin isoforms (LNE8s): hiPSC-derived corneal epithelial cells (iCECs) and other non-CECs rapidly adhered preferentially to LN332/411/511E8 and LN211E8, respectively, through differential expression of laminin-binding integrins. Furthermore, LN332E8 promoted epithelial cell proliferation but not that of the other eye-related cells, leading to non-CEC elimination by cell competition. Combining these features with magnetic sorting, highly pure iCEC sheets were fabricated. Thus, we established a simple method for isolating iCECs from various hiPSC-derived cells without using fluorescence-activated cell sorting. This study will facilitate efficient manufacture of iCEC sheets for corneal disease treatment and provide insights into target cell-specific scaffold selection.

  16. Generation and validation of a PITX2-EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells. International-journal Peer-reviewed

    Toru Okubo, Ryuhei Hayashi, Shun Shibata, Yuji Kudo, Yuki Ishikawa, Saki Inoue, Yuki Kobayashi, Ai Honda, Yoichi Honma, Satoshi Kawasaki, Kohji Nishida

    The Journal of Biological Chemistry 295 (11) 3456-3465 2020/03/13

    DOI: 10.1074/jbc.RA119.010713  

    More details Close

    PITX2 (Paired-like homeodomain transcription factor 2) plays important roles in asymmetric development of the internal organs and symmetric development of eye tissues. During eye development, cranial neural crest cells migrate from the neural tube and form the periocular mesenchyme (POM). POM cells differentiate into several ocular cell types, such as corneal endothelial cells, keratocytes, and some ocular mesenchymal cells. In this study, we used transcription activator-like effector nuclease technology to establish a human induced pluripotent stem cell (hiPSC) line expressing a fluorescent reporter gene from the PITX2 promoter. Using homologous recombination, we heterozygously inserted a PITX2-IRES2-EGFP sequence downstream of the stop codon in exon 8 of PITX2 Cellular pluripotency was monitored with alkaline phosphatase and immunofluorescence staining of pluripotency markers, and the hiPSC line formed normal self-formed ectodermal autonomous multizones. Using a combination of previously reported methods, we induced PITX2 in the hiPSC line and observed simultaneous EGFP and PITX2 expression, as indicated by immunoblotting and immunofluorescence staining. PITX2 mRNA levels were increased in EGFP-positive cells, which were collected by cell sorting, and marker gene expression analysis of EGFP-positive cells induced in self-formed ectodermal autonomous multizones revealed that they were genuine POM cells. Moreover, after 2 days of culture, EGFP-positive cells expressed the PITX2 protein, which co-localized with forkhead box C1 (FOXC1) protein in the nucleus. We anticipate that the PITX2-EGFP hiPSC reporter cell line established and validated here can be utilized to isolate POM cells and to analyze PITX2 expression during POM cell induction.

  17. The secretome of adipose-derived mesenchymal stem cells attenuates epithelial-mesenchymal transition in human corneal epithelium. International-journal Peer-reviewed

    Shun Shibata, Ryuhei Hayashi, Toru Okubo, Yuji Kudo, Koichi Baba, Yoichi Honma, Kohji Nishida

    Regenerative Therapy 11 114-122 2019/12

    DOI: 10.1016/j.reth.2019.06.005  

    More details Close

    Introduction: Epithelial-mesenchymal transition (EMT) induces the loss of cell-cell interactions in polarized epithelial cells and converts these cells to invasive mesenchymal-like cells. It is also involved in tissue fibrosis including that occurring in some ocular surface diseases such as pterygium and in subepithelial corneal fibrosis in limbal stem cell deficiency. Here, we examined the effects of the secretome of human adipose-derived mesenchymal stem cells (AdMSCs) on EMT in human corneal epithelial cells (CECs). Methods: EMT was induced with transforming growth factor-β (TGF-β) in primary human CECs isolated from the human corneal limbus. The effects of the AdMSC secretome on EMT in these cells or stratified CEC sheets were analyzed by co-cultivation experiments with the addition of AdMSC conditioned-medium. The expression of EMT-related genes and proteins in CECs was analyzed. The superstructure of CECs was observed by scanning electron microscopy. Furthermore, the barrier function of CEC sheets was analyzed by measuring transepithelial electrical resistance (TER). Results: The AdMSC secretome was found to suppress EMT-related gene expression and attenuate TGF-β-induced corneal epithelial dysfunction including the dissociation of cell-cell interactions and decreases in TER in constructed CEC sheets. Conclusions: The secretome of AdMSCs can inhibit TGF-β-induced EMT in CECs. These findings suggest that this could be a useful source for the treatment for EMT-related ocular surface diseases.

  18. Characterization of nucleolar localization and exclusion signals in terminal deoxynucleotidyltransferase interacting factor 2/estrogen receptor α-binding protein. International-journal Peer-reviewed

    Takashi Fukada*, Shun Shibata*, Toshihiro Ueda, Katsuhiko Sasaki, Yukiko Shimoida, Kaori Senda-Murata, Kenji Sugimoto

    Bioscience, Biotechnology, and Biochemistry 83 (7) 1255-1262 2019/07

    DOI: 10.1080/09168451.2019.1591265  

    More details Close

    Terminal deoxynucleotidyltransferase interacting factor 2/estrogen receptor α-binding protein (TdIF2/ERBP) is a multifunctional nucleolar protein. The nucleolar localization of TdIF2/ERBP is important for its functions because it promotes ribosomal RNA transcription. However, signal sequences that direct TdIF2/ERBP to the nucleolus are not well characterized. We examined the TdIF2/ERBP sequence using truncation and mutation analyses to determine whether the nucleosome binding and C-terminal domains of TdIF2/ERBP possess nucleolar localization signals (NoLSs). In these domains, four NoLSs that could direct the mCherry protein to the nucleolus were detected. In addition, a short stretch of hydrophobic residues (VLLVL) in the center of TdIF2/ERBP acted as a nucleolar exclusion signal, which reduced the nucleolar accumulation of mCherry-NoLS fusion proteins. These results would contribute to improving the prediction of NoLSs from protein sequences. The short, transferrable localization signals would be valuable tools for understanding the association between localization and functions of nucleolar proteins. Abbreviations TdIF2: terminal deoxynucleotidyltransferase interacting factor 2; ERBP: estrogen receptor α-binding protein; EGFP: enhanced green fluorescent protein; NLS: nuclear localization signal; NoLS: nucleolar localization signal; NoES: nucleolar exclusion signal; DAPI: 4',6-diamidino-2-phenylindole.

  19. RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells. International-journal Peer-reviewed

    Yuki Yoshino, Huicheng Qi, Ryo Kanazawa, Mami Sugamata, Kenta Suzuki, Akihiro Kobayashi, Kazuha Shindo, Ayako Matsuzawa, Shun Shibata, Shino Endo, Yutaro Miyanishi, Tatsuro Shimaoka, Chikashi Ishioka, Shin-Ichiro Kanno, Akira Yasui, Natsuko Chiba

    Oncogene 38 (16) 3077-3092 2019/04

    DOI: 10.1038/s41388-018-0647-8  

    More details Close

    Breast cancer gene 1 (BRCA1) is a tumor suppressor that is associated with hereditary breast and ovarian cancer. BRCA1 functions in DNA repair and centrosome regulation together with BRCA1-associated RING domain protein (BARD1), a heterodimer partner of BRCA1. Obg-like ATPase 1 (OLA1) was identified as a protein that interacts with BARD1. OLA1 regulates the centrosome by binding to and collaborating with BRCA1 and BARD1. We identified receptor for activated C kinase (RACK1) as a protein that interacts with OLA1. RACK1 directly bound to OLA1, the N-terminal region of BRCA1, and γ-tubulin, associated with BARD1, and localized the centrosomes throughout the cell cycle. Knockdown of RACK1 caused abnormal centrosomal localization of BRCA1 and abrogated centriole duplication. Overexpression of RACK1 increased the centrosomal localization of BRCA1 and caused centrosome amplification due to centriole overduplication. The number of centrioles in cells with two γ-tubulin spots was higher in cell lines derived from mammary tissue compared to those derived from other tissues. The effects of aberrant RACK1 expression level on centriole duplication were observed in cell lines derived from mammary tissue, but not in those derived from other tissues. Two BRCA1 variants, R133H and E143K, and a RACK1 variant, K280E, associated with cancer, which weakened the BRCA1-RACK1 interaction, interfered with the centrosomal localization of BRCA1 and reduced centrosome amplification induced by overexpression of RACK1. These results suggest that RACK1 regulates centriole duplication by controlling the centrosomal localization of BRCA1 in mammary tissue-derived cells and that this is dependent on the BRCA1-RACK1 interaction.

  20. Selective Laminin-Directed Differentiation of Human Induced Pluripotent Stem Cells into Distinct Ocular Lineages. International-journal Peer-reviewed

    Shun Shibata, Ryuhei Hayashi, Toru Okubo, Yuji Kudo, Tomohiko Katayama, Yuki Ishikawa, Junko Toga, Emiko Yagi, Yoichi Honma, Andrew J Quantock, Kiyotoshi Sekiguchi, Kohji Nishida

    Cell Reports 25 (6) 1668-1679 2018/11/06

    DOI: 10.1016/j.celrep.2018.10.032  

    More details Close

    The extracellular matrix plays a key role in stem cell maintenance, expansion, and differentiation. Laminin, a basement membrane protein, is a widely used substrate for cell culture including the growth of human induced pluripotent stem cells (hiPSCs). Here, we show that different isoforms of laminin lead to the selective differentiation of hiPSCs into different eye-like tissues. Specifically, the 211 isoform of the E8 fragment of laminin (LN211E8) promotes differentiation into neural crest cells via Wnt activation, whereas LN332E8 promotes differentiation into corneal epithelial cells. The immunohistochemical distributions of these laminin isoforms in the developing mouse eye mirrors the hiPSC type that was induced in vitro. Moreover, LN511E8 enables generation of dense hiPSC colonies due to actomyosin contraction, which in turn led to cell density-dependent YAP inactivation and subsequent retinal differentiation in colony centers. Thus, distinct laminin isoforms determine the fate of expanded hiPSCs into eye-like tissues.

  21. Use of homeobox gene expression patterns to determine anatomical regions of origin for body surface tissues derived from adult mice. International-journal Peer-reviewed

    Toru Okubo, Ryuhei Hayashi, Shun Shibata, Yuji Kudo, Yoichi Honma, Kohji Nishida

    Journal of Tissue Engineering and Regenerative Medicine 12 (6) 1412-1419 2018/06

    DOI: 10.1002/term.2673  

    More details Close

    Anatomical regions of the skin have distinct functions and anatomical characteristics, including thicker or thinner epidermis, more or fewer hair follicles, and lighter or darker skin. For a better therapeutic outcome of skin transplantation, site-specific characteristics of grafted tissues need to be taken into account in terms of their functionality and beauty. However, there is no method for evaluating positional information of epidermal cells. Homeobox genes are expressed along the anterior-posterior axis and direct the body plan in the animal development process. Although the expression of several HOX genes is known to be retained as the positional information in adult tissue, their expression patterns in the body surface tissues in adult mammals are still incompletely understood. In this study, we investigated the expression patterns of 40 homeobox genes, including 39 Hox genes and the paired box 6 (Pax6) gene, in body surface tissues of adult mice. On the basis of the results obtained, we proposed, for the first time, a method for determining anatomical regions of origin for body surface tissues derived from adult mice using Hox genes and Pax6. Evaluation of expression levels of at least 7 Hox genes and Pax6 should be sufficient to distinguish 11 anatomical body surface tissues derived from the adult mouse body. The proposed method may be useful not only for determining the origin of surface tissues from specific anatomical regions of the mammalian body but also for predicting positional information of epithelial cells generated from pluripotent stem cells.

  22. The BRCA1/BARD1-interacting protein OLA1 functions in centrosome regulation. International-journal Peer-reviewed

    Ayako Matsuzawa, Shin-Ichiro Kanno, Masahiro Nakayama, Hironori Mochiduki, Leizhen Wei, Tatsuro Shimaoka, Yumiko Furukawa, Kei Kato, Shun Shibata, Akira Yasui, Chikashi Ishioka, Natsuko Chiba

    Molecular Cell 53 (1) 101-14 2014/01/09

    DOI: 10.1016/j.molcel.2013.10.028  

    More details Close

    The breast and ovarian cancer-specific tumor suppressor BRCA1, along with its heterodimer partner BRCA1-associated RING domain protein (BARD1), plays important roles in DNA repair, centrosome regulation, and transcription. To explore further functions of BRCA1/BARD1, we performed mass spectrometry analysis and identified Obg-like ATPase 1 (OLA1) as a protein that interacts with the carboxy-terminal region of BARD1. OLA1 directly bound to the amino-terminal region of BRCA1 and γ-tubulin. OLA1 localized to centrosomes in interphase and to the spindle pole in mitotic phase, and its knockdown resulted in centrosome amplification and the activation of microtubule aster formation. OLA1 with a mutation observed in breast cancer cell line, E168Q, failed to bind BRCA1 and rescue the OLA1 knockdown-induced centrosome amplification. BRCA1 variant I42V also abrogated the binding of BRCA1 to OLA1. These findings suggest that OLA1 plays an important role in centrosome regulation together with BRCA1.

Show all ︎Show first 5

Misc. 30

  1. 【胎盤形成と母児連関 発達を運命づけるメカニズム】ヒト胚着床の試験管内再構築と分子機序

    柴田 峻, 有馬 隆博

    実験医学 43 (4) 486-491 2025/03

    Publisher: (株)羊土社

    ISSN: 0288-5514

  2. 【遺伝診療・ゲノム医療の最新動向-産婦人科医のためのナビゲーション-】総論 ゲノムインプリンティングとヒト疾患

    柴田 峻, 濱田 裕貴, 有馬 隆博

    産科と婦人科 92 (2) 152-158 2025/02

    Publisher: (株)診断と治療社

    ISSN: 0386-9792

  3. ヒト生殖メカニズム解明のための研究フロントライン ヒト胚着床モデルの作製

    柴田 峻, 有馬 隆博

    日本生殖医学会雑誌 69 (4) 304-304 2024/10

    Publisher: (一社)日本生殖医学会

    ISSN: 1881-0098

  4. ヒト子宮内膜オルガノイドモデルを用いたヒト着床現象の模倣

    柴田 峻, 有馬 隆博

    日本生殖内分泌学会雑誌 29 23-26 2024/08

    Publisher: 日本生殖内分泌学会

    ISSN: 1348-8031

  5. 新たな子宮内膜オルガノイドの確立とヒト胚着床現象のin vitroでの再現

    柴田 峻, 小林 枝里, 有馬 隆博

    オルガノイド研究 ~培養・作製、活用、臨床応用~ 2024/08

  6. 新たな子宮内膜オルガノイドの確立とヒト胚着床の模倣

    柴田 峻, 遠藤 俊, Nagai Luis Augusto Eijy, 中戸 隆一郎, 岡江 寛明, 有馬 隆博

    日本内分泌学会雑誌 99 (5) 1548-1548 2024/04

    Publisher: (一社)日本内分泌学会

    ISSN: 0029-0661

    eISSN: 2186-506X

  7. 胎盤幹細胞の創薬研究への応用

    堀 武志, 梶 弘和, 柴田 峻, 有馬 隆博

    生体医歯工学共同研究拠点成果報告書 2023年度 61-61 2024/04

    Publisher: 東京医科歯科大学生体材料工学研究所

  8. ヒト胚着床オルガノイドモデルの創出と生殖補助医療への応用に向けた研究

    柴田 峻

    医科学応用研究財団研究報告 41 133-137 2024/02

    Publisher: (公財)鈴木謙三記念医科学応用研究財団

    ISSN: 0914-5117

    eISSN: 2185-2561

  9. Recapitulating human embryo implantation in vitro

    柴田峻, 有馬隆博

    医学のあゆみ 291 (8) 2024

    ISSN: 0039-2359

  10. ヒト着床モデルによる母胎間分子シグナル機構の解明

    柴田 峻

    上原記念生命科学財団研究報告集 37 1-5 2023/12

    Publisher: (公財)上原記念生命科学財団

    ISSN: 2433-3441

    eISSN: 2433-3441

  11. 【図説 産婦人科医のための臨床遺伝学必修知識I】知っておきたいエピゲノムの基礎知識

    柴田 峻, 小林 枝里, 有馬 隆博

    産婦人科の実際 72 (8) 781-786 2023/08

    Publisher: 金原出版(株)

    ISSN: 0558-4728

  12. 【ヒトの再生をめぐる諸問題】胎盤発生と細胞運命決定機構

    柴田 峻, 小林 記緒, 岡江 寛明, 有馬 隆博

    HORMONE FRONTIER IN GYNECOLOGY 30 (1) 29-36 2023/03

    Publisher: (株)メディカルレビュー社

    ISSN: 1340-220X

  13. 妊娠高血圧症候群における細胞性栄養膜細胞を用いたマルチオミックス解析

    遠藤 俊, 柴田 峻, 小林 枝里, 清水 孝規, 大池 輝, 小林 記緒, 岡江 寛明, 濱田 裕貴, 齋藤 昌利, 有馬 隆博, 八重樫 伸生

    日本絨毛性疾患研究会・日本胎盤学会学術集会プログラム・抄録集 40th-30th (CD-ROM) 2022

  14. 脂肪組織由来間葉系幹細胞の分泌因子によるドライアイ治療薬開発に向けた基礎的検討

    今泉務, 今泉務, 林竜平, 林竜平, 工藤裕司, 工藤裕司, 李小琴, 李小琴, 柴田峻, 柴田峻, 大久保徹, 大久保徹, 石井強, 本間陽一, 西田幸二

    日本再生医療学会総会(Web) 21st 2022

  15. 生殖医学研究の最前線-進歩し続ける基礎研究- 疾患特異的ヒト胎盤幹細胞の樹立

    岡江 寛明, 清水 孝規, 遠藤 俊, 大池 輝, 小林 記緒, 柴田 峻, 小林 枝里, 有馬 隆博

    日本生殖医学会雑誌 66 (4) 227-227 2021/10

    Publisher: (一社)日本生殖医学会

    ISSN: 1881-0098

  16. Human placental development and stem cells

    柴田峻, 岡江寛明, 有馬隆博

    生体の科学 72 (2) 2021

    ISSN: 0370-9531

  17. Establishment of Placental disease models by human TS cells

    大池輝, 小林枝里, 小林記緒, 柴田峻, 岡江寛明, 北村茜, 宮内尚子, 有馬隆博

    Bio Clinica 36 (5) 2021

    ISSN: 0919-8237

  18. 間葉系幹細胞由来分泌因子よるドライアイ治療薬開発に向けた基礎的検討

    今泉務, 林竜平, 工藤裕司, 今泉務, 林竜平, 工藤裕司, 李小琴, 柴田峻, 柴田峻, 大久保徹, 石井強, 本間陽一, 大久保徹, 石井強, 本間陽一, 西田幸二

    日本眼薬理学会プログラム・講演抄録集 41st 2021

  19. ヒトES,iPS細胞からの角膜上皮細胞の誘導

    片山朋彦, 林竜平, 大久保徹, 大久保徹, 柴田峻, 柴田峻, 高柳泰, 安川裕子, 山手百合香, 小林由紀, 森田未央, 西田幸二

    日本再生医療学会総会(Web) 19th 2020

  20. Cell-type-specific adhesion to laminin isoforms and cell competition enable purification of iPS cell-derived corneal epithelium

    柴田峻, 柴田峻, 林竜平, 工藤裕司, 工藤裕司, 大久保徹, 大久保徹, 今泉務, 今泉務, 片山朋彦, 石川幸, 小林由紀, 栂純子, 谿口征雅, 本間陽一, 本間陽一, 関口清俊, 西田幸二

    日本結合組織学会学術大会抄録集 52nd 2020

  21. iPS角膜上皮シート作製工程の効率化検討-FACSを用いない角膜上皮細胞単離法の開発-

    柴田峻, 柴田峻, 林竜平, 工藤裕司, 工藤裕司, 大久保徹, 大久保徹, 片山朋彦, 石川幸, 小林由紀, 栂純子, 谿口征雅, 本間陽一, 本間陽一, 関口清俊, 西田幸二

    日本再生医療学会総会(Web) 18th 2019

  22. ラミニンアイソフォームを利用したiPS細胞の選択的運命制御とiPS角膜上皮細胞の単離

    柴田峻, 柴田峻, 林竜平, 大久保徹, 大久保徹, 工藤裕司, 工藤裕司, 片山朋彦, 石川幸, 小林由紀, 栂純子, 八木恵美子, 谿口征雅, 本間陽一, 本間陽一, QUANTOCK Andrew J., 関口清俊, 西田幸二

    日本結合組織学会学術大会抄録集 51st 2019

  23. 足場依存的iPS細胞コロニーの細胞密度勾配形成と外胚葉分化

    柴田峻, 柴田峻, 林竜平, 林竜平, 大久保徹, 工藤裕司, 片山朋彦, 石川幸, 栂純子, 八木恵美子, 本間陽一, QUANTOCK Andrew J., 関口清俊, 西田幸二

    日本再生医療学会総会(Web) 17th 2018

  24. ラミニンアイソフォームはiPS細胞からの眼細胞発生を制御する

    柴田峻, 柴田峻, 林竜平, 林竜平, 大久保徹, 大久保徹, 工藤裕司, 工藤裕司, 片山朋彦, 栂純子, 八木恵美子, 本間陽一, 本間陽一, 関口清俊, 西田幸二

    再生医療 16 2017

    ISSN: 1347-7919

  25. 角膜上皮細胞における上皮間葉転換と間葉系幹細胞分泌因子の効果

    柴田峻, 柴田峻, 大久保徹, 大久保徹, 林竜平, 西田幸二

    再生医療 15 2016

    ISSN: 1347-7919

  26. 間葉系幹細胞由来エクソソームによる角膜上皮幹細胞のコロニー形成促進効果

    大久保徹, 大久保徹, 柴田峻, 柴田峻, 林竜平, 西田幸二

    再生医療 15 2016

    ISSN: 1347-7919

  27. 個別化医療のための癌関連分子の機能解析

    千葉奈津子, 柵木絵美子, 柏木梨佐, 柴田峻, 古川裕美子, 松澤綾子

    ナノ医工学年報2010 東北大学グローバルCOEプログラム 新世紀世界の成長焦点に築くナノ医工学拠点 2011

  28. 個別化医療のための分子イメージング技術を用いた癌関連分子の機能解析

    千葉 奈津子, 古川 裕美子, 柴田 峻

    ナノ医工学年報 5 (1) 231-240 2011

    Publisher: 東北大学グローバルCOEプログラム「新世紀世界の成長焦点に築くナノ医工学拠点」

    ISSN: 1882-4692

  29. BRCA1はDNA単鎖切断修復に関与する

    柏木 梨佐, 古川 裕美子, 魏 雷震, 宇井 彩子, 松澤 綾子, 柵木 絵美子, 柴田 峻, 石岡 千加史, 安井 明, 千葉 奈津子

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 83回・33回 2P-0461 2010/12

    Publisher: (公社)日本生化学会

  30. DNA損傷に続くBRCA1/BARD1発現レベルの制御メカニズム(Regulatory mechanism of the level of BRCA1/BARD1 expression following DNA damage)

    柵木 絵美子, 菅野 新一郎, 松澤 綾子, 柏木 梨佐, 柴田 峻, 古川 裕美子, 魏 雷震, 石岡 千加史, 安井 明, 千葉 奈津子

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 83回・33回 2P-0462 2010/12

    Publisher: (公社)日本生化学会

Show all ︎Show first 5

Presentations 10

  1. Recapitulating human embryo implantation using stem cells and organoids Invited

    Shun Shibata

    Virtual Gastrulation Zoom Talks 2025/03/12

  2. Modeling the interphase between embryo and endometrium to understand embryo implantation in humans Invited

    Shun Shibata

    Foundation for Reproductive Medicine Conference 2024, NY 2024/12/06

  3. ヒト胚着床モデルの作製 Invited

    柴田 峻

    第69回日本生殖医学会学術講演会・総会 シンポジウム 2024/11/15

  4. 幹細胞・オルガノイドを用いたヒト胚着床現象の試験管内での再現 Invited

    柴田 峻, 有馬 隆博

    第20回 Top Runners in TRS 2024/08/05

  5. Modeling Embryo–Endometrial Interface Recapitulating Human Embryo Implantation

    Shun Shibata, Takahiro Arima

    ISSCR 2024 2024/07/09

  6. 胚着床アセンブロイドモデルと母児間細胞相互作用の検討 Invited

    柴田 峻, 有馬 隆博

    日本組織培養学会第96回大会 2024/06/27

  7. Modeling Embryo–Endometrial Interface Recapitulating Human Embryo Implantation

    Shun Shibata, Luis A. E. Nagai, Akira Oike, Eri H. Kobayashi, Norio Kobayashi, Ryuichiro Nakato, Mikita Suyama, Hiroaki Okae, Takahiro Arima

    IHEC Annual Meeting 2023 2023/11/13

  8. 胎児-母体アセンブロイドを用いたin vitroにおけるヒト胚着床現象の再現 Invited

    柴田 峻, 遠藤 俊, 大池 輝, 小林 枝里, Luis Augusto Eijy Nagai, 中戸 隆一郎, 岡江 寛明, 有馬 隆博

    第41回日本受精着床学会総会・学術講演会 2023/07/27

  9. 妊娠高血圧症候群における細胞性栄養膜細胞を用いたマルチオミックス解析

    遠藤 俊, 柴田 峻, 小林 枝里, 清水 孝規, 大池 輝, 小林 記緒, 岡江 寛明, 濱田 裕貴, 齋藤 昌利, 有馬 隆博, 八重樫 伸生

    第30回日本胎盤学会学術集会 2022/11/25

  10. ヒト胚着床モデル-母胎アセンブロイド-の開発 Invited

    柴田 峻, 岡江 寛明, 有馬 隆博

    ART FORUM ’21 2021/07/15

Show all Show first 5

Industrial Property Rights 8

  1. 子宮内膜モデル、子宮内膜モデルの作製方法、及び子宮内膜着 床モデル

    柴田峻, 岡江寛明, 有馬隆博

    特許第7710755号

    Property Type: Patent

  2. 重層扁平上皮細胞の正常分化・成熟促進剤、上皮疾患治療剤及び重層扁平上皮細胞の正常分化・成熟促進方法

    西田 幸二, 林 竜平, 柴田 峻, 大久保 徹, 本間 陽一

    特許第7391327号

    Property Type: Patent

  3. 上皮疾患に対する治療及び/又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤

    西田 幸二, 林 竜平, 本間 陽一, 大久保 徹, 柴田 峻

    特許第7057557号

    Property Type: Patent

  4. 多能性幹細胞の分化制御方法

    西田 幸二, 関口 清俊, 林 竜平, 柴田 峻

    特許第6942363号

    Property Type: Patent

  5. 間葉系幹細胞由来エキソソーム

    西田 幸二, 林 竜平, 本間 陽一, 大久保 徹, 柴田 峻

    特許第6923134号

    Property Type: Patent

  6. 角膜上皮細胞集団の製造方法

    西田 幸二, 林 竜平, 柴田 峻

    特許第6857918号

    Property Type: Patent

  7. コラーゲンリモデリング剤およびそれを用いた皮膚外用剤、飲食品、並びに美容方法。

    西田 浩之, 羽賀 雅俊, 柴田 峻

    特許第6782075号

    Property Type: Patent

  8. ルミカン産生促進剤およびそれを用いた皮膚外用剤、飲食品、並びに美容方法。

    西田 浩之, 羽賀 雅俊, 柴田 峻

    特許第6782074号

    Property Type: Patent

Show all Show first 5

Research Projects 9

  1. Implantation organoid model using human multilevel stem cells and elucidation of immune tolerance mechanism

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2024/04/01 - 2028/03/31

  2. 三次元多階層細胞モデルを駆使した着床免疫パラダイムの深層解明

    柴田 峻

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 若手研究

    Institution: 東北大学

    2024/04/01 - 2027/03/31

  3. ヒト胚着床オルガノイドモデルを活用した母子間競合的細胞コミュニケーションの解析

    柴田 峻

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 学術変革領域研究(A)

    Institution: 東北大学

    2024/04/01 - 2026/03/31

  4. ヒト胎盤の発生・分化を調節する分子メカニズムと疾患の病態解明

    小林 枝里, 柴田 峻

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 基盤研究(C)

    Institution: 東北大学

    2023/04/01 - 2026/03/31

  5. ヒト胎盤形成のエピゲノム制御と母体-胎盤間分子シグナルコミュニケーションの理解

    有馬 隆博, 小林 記緒, 柴田 峻, 小林 枝里

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 基盤研究(A)

    Category: 基盤研究(A)

    Institution: 東北大学

    2021/04/05 - 2025/03/31

    More details Close

    近年の晩婚化と高齢出産の増加により、胎盤のエピゲノムに異常を示す流産や妊娠高血圧症候群(HDP)の発症頻度が、年々増加傾向を示している。本研究では、ユニークなエピゲノム特性を示すヒト胎盤において、いかなる分子機構を介して、エピジェネティックな制御が行われているのか明らかにすることを目的としている。具体的には、胚発生モデルとHDP疾患胎盤のエピゲノムについて解析し、母体と胎盤間のシグナル伝達経路について理解することを目指している。そのため、1)ヒト胚盤胞様構造物と母体細胞(子宮内膜細胞)を用いて、母体内の胎盤形成と分化を高度に模倣する三次元オルガノイドモデルを作製し、母体-胎盤間の分子ネットワークを包括的に理解 2)エピゲノム異常を示すHDPの病態を再現するモデルを作製し、エピゲノム制御の理解を行う。まず初年度は、ヒト胚盤胞様構造物と子宮内膜細胞の共培養による三次元ヒト胚発生オルガノイドモデルの作製とHDP胎盤由来TS細胞株の樹立することおよび微量サンプルに適応した多階層オミックス解析について、研究を開始した。胚発生オルガノイドモデルの作製では、子宮内膜の肥厚やTS細胞の浸潤・分化能の変化を経時的に観察することに成功した。また、妊娠中期の栄養膜細胞を用いたTS細胞の樹立では、SALL4が必要であることを突き止めた。しかし、SALL4を導入したTS細胞では、11番染色体長腕部分に高頻度にインプリント遺伝子領域のヘテロ接合性の消失(LOH)を認めた。そのため、この領域の遺伝子発現を制御するKIP2の発現を調節するため、Sh KIP2を遺伝子導入した。現在、作製した疾患TS細胞がLOHを回避し、疾患特異的なエピゲノムの特徴を保持しているかどうか検討している。

  6. ヒト胎盤幹細胞を用いた革新的な周産期疾患モデリング

    岡江 寛明, 柴田 峻

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 基盤研究(B)

    Category: 基盤研究(B)

    Institution: 東北大学

    2021/04/01 - 2024/03/31

    More details Close

    本研究の目的は、ヒト胎盤幹細胞(TS細胞)を活用し、妊娠20週以降の高血圧と臓器障害を特徴とする妊娠高血圧腎症の発症機構に迫ることである。我々は既に、妊娠初期のヒト胎盤からTS細胞を樹立する手法を確立しているが、同様の手法を妊娠中期以降の胎盤に適用することはできない。そこで、本年度はリプログラミングの手法を用い、妊娠中期以降の胎盤からTS細胞を誘導する技術の確立を試みた。まず、妊娠初期の胎盤で特異的に発現する転写因子をクローニングし、様々な組み合わせで妊娠後期の胎盤から採取した栄養膜細胞に導入した。遺伝子導入後の細胞をヒトTS細胞用の培地で培養したところ、転写因子Aおよびリプログラム因子Bを組み合わせた場合のみ、低効率ではあるがTS細胞様のコロニーを得ることに成功した。この条件をベースとしてさらに条件検討を重ねた結果、細胞増殖を抑制する遺伝子CおよびDを一過的にノックダウンすることで、効率良くTS細胞を樹立可能であることを見出した。得られたTS細胞は正常な核型を有し、高い増殖能と胎盤を構成する合胞体および絨毛外栄養膜細胞への分化能を保持していた。さらに、遺伝子の発現パターンやDNAメチル化パターンも、妊娠初期の胎盤に由来するTS細胞のものとよく似ていた。最適化したリプログラミングの条件を用いて、計13例の満期正常胎盤よりヒトTS細胞を樹立することに成功した。また、妊娠高血圧症候群に由来する胎盤組織を用いたヒトTS細胞の樹立にも着手した。

  7. ヒト胚発生過程を可視化する多階層幹細胞オルガノイドモデルの創出

    柴田 峻

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業 若手研究

    Category: 若手研究

    Institution: 東北大学

    2021/04/01 - 2024/03/31

    More details Close

    哺乳類の中でもヒト胚は、着床後、子宮内膜に深く埋没していくユニークな特徴を示す。その間の胚発生過程では、母体との複雑かつ秩序立った相互作用が起こると考えられているが、その大部分は明らかではない。また、その分子機構の破綻が原因で、着床不全や流産を引き起こすと推測されるが、その病態の理解や治療法の開発も遅れている。その要因として、ヒト初期胚を用いる研究には倫理的な制約があるとともに、代替となる適切な研究モデルの欠如が挙げられる。最近、本研究室では世界で初めてヒト栄養膜幹(TS)細胞を樹立することに成功した。本研究では、胎児・母体双方の細胞について、細胞数や形態、時空間座標をヒト胚発生に即して培養し、段階的に混合しながら三次元培養を行い、胚-母体オルガノイドを創出する。オルガノイドモデルを創出するにあたり、胎児・母体側のモデル確立を行った。胚モデルについては、胚体系譜の細胞としてヒトES細胞を、胚体外系譜の細胞としてヒトTS細胞を用い、浮遊培養による共培養を行った。両者についてそれぞれ恒常的に蛍光タンパク質を発現する細胞株を樹立し、生きたまま凝集体形成過程や共培養過程を追跡可能にした。また、母体側のモデルとして、先行研究に基づき、複数のドナーの中絶検体組織より子宮内膜上皮オルガノイドの樹立と間質細胞の単離を行った。それぞれについて系譜マーカーの発現と母体のモデルについては、ホルモン応答能の確認を行った。また、両者の発生を促進する三次元したでの共培養条件を決定した。

  8. ART(生殖補助医療)における胚着床率の劇的向上に向けた多階層幹細胞・着床ニッチ構築を目指すヒト胚発生オルガノイドモデル作製

    Offer Organization: 国立研究開発法人日本医療研究開発機構

    2021/05 - 2024/03

  9. Investigation of the role of Hippo-YAP signals regulating extraembryonic lineages

    Shibata Shun

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Research Activity Start-up

    Institution: Tohoku University

    2020/09/11 - 2022/03/31

    More details Close

    We investigated the involvement of Hippo-YAP signaling in the fate determination and maintenance of extraembryonic lineages using human stem cell lines. Immunostaining results showed that YAP localized in the nucleus and cytoplasm in human naive ES cells. In human TS cells, YAP was predominantly localized in the nucleus. We also analyzed localization of YAP during ES-TS cell trans-differentiation. Decreased expression of OCT4 and nuclear translocation of YAP were confirmed over time. Moreover, the nuclear translocation of YAP was prominent in GATA3, a maker of trophoblast lineage, -positive cells. Furthermore, YAP-TEAD inhibitor verteporfin inhibited cell proliferation of human TS cells in a concentration-dependent manner. These results suggest the involvement of YAP in the differentiation of human ES cells into extraembryonic lineage and the maintenance of TS cells.

Show all Show first 5

Social Activities 2

  1. 高校生向け実験教室 (盛岡南高校)

    2014/06/23 - 2014/06/23

  2. 高校生向け実験教室 (石巻高校)

    2013/10/05 - 2013/10/06

Media Coverage 9

  1. 政府の日本医療研究開発大賞 不妊治療法の研究評価

    山形新聞社 山形新聞 地域

    2025/01

    Type: Newspaper, magazine

  2. 人の受精卵 着床を再現

    読売新聞社 読売新聞 くらしサイエンス

    2024/04

    Type: Newspaper, magazine

  3. 不妊や流産の解明に期待

    日本経済新聞社 日本経済新聞 会員限定記事

    2024/04

    Type: Newspaper, magazine

  4. ヒト受精卵の着床を再現、不妊の解明など活用へ

    日本経済新聞社 日本経済新聞 科学&新技術

    2024/04

    Type: Newspaper, magazine

  5. Tohoku University successfully develop endometrial organoid model and reproduce human embryo implantation

    JST Science Japan Latest News

    2024/04

    Type: Internet

  6. 「着床」再現、詳細観察 疑似胚盤胞と子宮内膜モデルで―不妊治療改善に期待・東北大など

    時事ドットコムニュース 社会

    2024/02

    Type: Internet

  7. 阪大とロート製薬、iPS角膜上皮細胞の安価で簡便な純化法を確立

    日本経済新聞社 日本経済新聞 医薬・医療

    2020/04

    Type: Newspaper, magazine

  8. 【ロート製薬/大阪大学】iPS細胞の共同研究‐眼の様々な細胞に分化、眼疾患への実用化に前進

    薬事日報社 薬事日報 電子版

    2018/12

    Type: Newspaper, magazine

  9. 阪大とロート製薬、iPS細胞から様々な眼の細胞を選択的に誘導することに成功

    日本経済新聞社 日本経済新聞 医薬・医療

    2018/12

    Type: Newspaper, magazine

Show all Show first 5

Academic Activities 1

  1. 第2回東北テックグランプリ 審査員

    2024/11/23 - 2024/11/23

    Activity type: Competition, symposium, etc.

Other 7

  1. The Teaching and Course Design Certificate

    More details Close

    Center for Professional Development and Inclusive Excellence (C-Hub) at Okinawa Institute of Science and Technology

  2. 日本組織培養学会認定細胞培養士

  3. 日本バイオインフォマティクス学会認定技術者

  4. 日本再生医療学会 臨床培養士

  5. グロービス経営大学院 クリティカルシンキング講座 修了(総合成績 A)

  6. JBAバイオリーダーズ研修修了

  7. 高等学校教諭専修免許(理科)

Show all Show first 5